The US Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in ...

She highlighted how the new subcutaneous regimen could provide ... This innovation aims to reduce inflammation at the cellular level to improve outcomes for patients. If approved, the SC induction ...